FDA clears Oticon Medical’s hearing loss implant

Oticon Medical announced today that the FDA granted clearance for its Sentio transcutaneous bone conduction hearing system.

The system includes the Sentio 1 Mini external sound processor and Sentio Ti implant, placed under the skin. Askim, Sweden-based Oticon says it’s the smallest transcutaneous bone conduction hearing system to date. The company says it delivers the proven benefits of its Ponto bone-anchored hearing system, but in a transcutaneous option.

Ponto and other percutaneous bone-anchored hearing systems use skin-protruding abutments. Meanwhile, Sentio provides an alternative, keeping the skin intact and providing freedom of choice.

Oticon designed the Sentio 1 Mini processor with a focus on user comfort and ease of use. Its design and slim profile make it 26% lighter than alternatives, the company says. It also provides access to a 360-degree sound experience with a bandwidth of 9.5kHz.

Sign up for Blog Updates